Persistent Short Sleep Duration From Pregnancy to 2 to 7 Years After Delivery and Metabolic Health
- PMID: 39724370
- PMCID: PMC11672157
- DOI: 10.1001/jamanetworkopen.2024.52204
Persistent Short Sleep Duration From Pregnancy to 2 to 7 Years After Delivery and Metabolic Health
Abstract
Importance: Short sleep duration during pregnancy and the perimenopausal period has been associated with adverse cardiometabolic outcomes. However, it remains unclear how sleep duration changes after delivery and whether such changes are associated with the cardiometabolic health of birthing people.
Objective: To investigate whether persistently short sleep during pregnancy and after delivery is associated with incident hypertension and metabolic syndrome.
Design, setting, and participants: This secondary analysis of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be Heart Health Study (NuMoM2b-HHS), an ongoing prospective cohort study, was conducted between September 5, 2023, and March 1, 2024, in 8 US academic medical centers. Participants were aged 18 years or older at NuMoM2b enrollment; recruited during their first pregnancy between October 1, 2010, and September 30, 2013; and followed up for a mean (SD) of 3.1 (0.9) years after delivery.
Exposures: Self-reported short sleep duration (<7 hours) during pregnancy and 2 to 7 years after delivery was defined as persistent short sleep.
Main outcomes and measures: Incident hypertension and metabolic syndrome (MetS) at follow-up. Regression models were used to estimate relative risks of incident hypertension and MetS by sleep duration pattern. Hypertension analyses excluded participants with hypertension at baseline, and MetS analyses excluded participants with MetS at baseline. Multivariable models included a priori covariates of baseline age and time from delivery to follow-up. Incident hypertension analyses included an additional covariate of body mass index at baseline.
Results: Among 3922 participants (mean [SD] age, 27.3 [5.4] years; 598 Hispanic [15.2%], 485 non-Hispanic Black [12.4%], and 2542 non-Hispanic White [64.8%]), 565 individuals (14.4%) experienced persistent short sleep. Non-Hispanic Black (adjusted odds ratio [aOR], 2.17; 95% CI, 1.59-2.97) and unmarried (aOR, 1.68, 95% CI, 1.29-2.19) participants were significantly more likely to experience persistent short sleep compared with non-Hispanic White and married participants, respectively. Persistent short sleep was associated with higher odds of incident MetS (aOR, 1.60; 95% CI, 1.21-2.11) but not incident hypertension (aOR, 0.91; 95% CI, 0.69-1.19).
Conclusions and relevance: In this study, short sleep duration that persisted from pregnancy to 2 to 7 years after delivery was associated with a greater risk for adverse cardiometabolic outcomes. Future studies should explore whether sleep-targeted interventions during and after pregnancy are associated with improved cardiometabolic health outcomes, particularly among populations at increased risk.
Conflict of interest statement
Figures



Similar articles
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394
-
Maternal and neonatal outcomes of elective induction of labor.Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257. Evid Rep Technol Assess (Full Rep). 2009. PMID: 19408970 Free PMC article.
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. doi: 10.1002/14651858.CD003510.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. PMID: 17253490 Updated.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
Development and external validation of a nomogram for predicting sepsis following flexible ureteroscopy.Eur J Med Res. 2025 Jun 13;30(1):479. doi: 10.1186/s40001-025-02754-6. Eur J Med Res. 2025. PMID: 40514708 Free PMC article.
References
-
- Rosamond W, Flegal K, Friday G, et al. ; American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69-e171. doi:10.1161/CIRCULATIONAHA.106.179918 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
- K23 AG088497/AG/NIA NIH HHS/United States
- P30 AG059988/AG/NIA NIH HHS/United States
- R01 HL105549/HL/NHLBI NIH HHS/United States
- U10 HL119991/HL/NHLBI NIH HHS/United States
- U10 HL119989/HL/NHLBI NIH HHS/United States
- U10 HL120034/HL/NHLBI NIH HHS/United States
- U10 HL119990/HL/NHLBI NIH HHS/United States
- U10 HL120006/HL/NHLBI NIH HHS/United States
- U10 HL119992/HL/NHLBI NIH HHS/United States
- U10 HL120019/HL/NHLBI NIH HHS/United States
- U10 HL119993/HL/NHLBI NIH HHS/United States
- U10 HL120018/HL/NHLBI NIH HHS/United States
- U01 HL145358/HL/NHLBI NIH HHS/United States
- U10 HD063036/HD/NICHD NIH HHS/United States
- U10 HD063072/HD/NICHD NIH HHS/United States
- U10 HD063047/HD/NICHD NIH HHS/United States
- U10 HD063037/HD/NICHD NIH HHS/United States
- U10 HD063041/HD/NICHD NIH HHS/United States
- U10 HD063020/HD/NICHD NIH HHS/United States
- U10 HD063046/HD/NICHD NIH HHS/United States
- U10 HD063048/HD/NICHD NIH HHS/United States
- U10 HD063053/HD/NICHD NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- UL1 TR000153/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical